Dr. Engelsgjerd oversees coverage of the oncology sector, including marketed products, drug development, clinical trial design, emerging molecular targets, diagnostics, and cancer genomics/personalized medicine. He joined inThought from Coleman Research Group where he was Director of Healthcare Research.

Previously, Dr. Engelsgjerd spent five years analyzing the biopharma industry for the investment community at Banc of America Securities, UBS Securities, and Reuters Insight. Before coming to Wall Street, he was at Research Corporation Technologies, an early-stage life sciences venture capital fund, where he vetted investment opportunities and helped to manage portfolio companies. Dr. Engelsgjerd has also served as Director of Clinical Affairs at Veritas Medicine, an eHealth start-up company aimed at streamlining clinical trials recruitment. He completed a general surgery internship at the Barnes-Jewish Hospital (Washington University) and an anatomic pathology residency at the Brigham and Women’s Hospital. Dr. Engelsgjerd earned his medical degree at the University of California, San Francisco, where he received the Dean’s Research Award. He graduated summa cum laude from the University of Arizona with a Bachelor of Science with Honors in Molecular & Cellular Biology.